Latest filing published 04 May 2023 for Ginkgo Bioworks Holdings, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Marie E. Fallon: trading record in brief
Marie E. Fallon discloses dealings in Ginkgo Bioworks Holdings, Inc. to SEC (Form 4). Between 1 October 2021 and 2 May 2023, the trades on record add up to 30 filings.
Sales make up the whole of the open-market record (10 sales, €437k). Besides market trades, the filings include 20 option exercises. So far in 2023, the count stands at no purchases and 5 sales.
The newest entry dates from 4 May 2023: an open-market sale of €8,432, in Ginkgo Bioworks Holdings, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Marie E. Fallon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,683 sharesClass A Common StockSEC:0001127602-23-014600:0
- 13,684 sharesClass A Common StockSEC:0001127602-23-012625:0
- 13,683 sharesClass A Common StockSEC:0001127602-23-008805:0
- 13,684 sharesClass A Common StockSEC:0001127602-23-003407:0
- 15,350 sharesClass A Common StockSEC:0001127602-23-001108:0
- 13,350 sharesClass A Common StockSEC:0000899243-22-037732:0
- 13,350 sharesClass A Common StockSEC:0000899243-22-035327:0
- 102,254 shares@ US$3.25100.0% of flowClass A Common StockSEC:0000899243-22-033326:0
- 6,134 sharesClass A Common StockSEC:0000899243-22-033325:0
- 6,134 sharesClass A Common StockSEC:0000899243-22-032863:0
10 of 10 declarations
